Abstract:While the term artificial intelligence and the concept of deep learning are not new, recent advances in high-performance computing, the availability of large annotated data sets required for training, and novel frameworks for implementing deep neural networks have led to an unprecedented acceleration of the field of molecular (network) biology and pharmacogenomics. The need to align biological data to innovative machine learning has stimulated developments in both data integration (fusion) and knowledge representation, in the form of heterogeneous, multiplex, and biological networks or graphs. In this chapter we briefly introduce several popular neural network architectures used in deep learning, namely, the fully connected deep neural network, recurrent neural network, convolutional neural network, and the autoencoder. Deep learning predictors, classifiers, and generators utilized in modern feature extraction may well assist interpretability and thus imbue AI tools with increased explication, potentially adding insights and advancements in novel chemistry and biology discovery.The capability of learning representations from structures directly without using any predefined structure descriptor is an important feature distinguishing deep learning from other machine learning methods and makes the traditional feature selection and reduction procedures unnecessary. In this chapter we briefly show how these technologies are applied for data integration (fusion) and analysis in drug discovery research covering these areas: (1) application of convolutional neural networks to predict ligand–protein interactions; (2) application of deep learning in compound property and activity prediction; (3) de novo design through deep learning. We also: (1) discuss some aspects of future development of deep learning in drug discovery/chemistry; (2) provide references to published information; (3) provide recently advocated recommendations on using artificial intelligence and deep learning in -omics research and drug discovery.

Low Data Drug Discovery with One-Shot Learning

Advancing Drug Discovery with Deep Learning: Harnessing Reinforcement Learning and One-Shot Learning for Molecular Design in Low-Data Situations

Few-Shot Learning for Low-Data Drug Discovery

Deep learning for low-data drug discovery: hurdles and opportunities

Traversing Chemical Space with Active Deep Learning: A Computational Framework for Low-data Drug Discovery

Meta Learning With Graph Attention Networks for Low-Data Drug Discovery

Transfer Learning for Drug Discovery

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

A deep-learning view of chemical space designed to facilitate drug discovery

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Few-shot learning via graph embeddings with convolutional networks for low-data molecular property prediction

Unsupervised Learning in Drug Design from Self-Organization to Deep Chemistry

The rise of deep learning in drug discovery

Zero-shot Learning of Drug Response Prediction for Preclinical Drug Screening

Implementation of Deep Learning in Drug Design

MoleHD: Ultra-Low-Cost Drug Discovery using Hyperdimensional Computing

A compact review of progress and prospects of deep learning in drug discovery

ChemVise: Maximizing Out-of-Distribution Chemical Detection with the Novel Application of Zero-Shot Learning

Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data

From Data to Drugs: Harnessing Machine Learning's Potential for Drug Discovery